Skip to main content
Category

Uncategorized

GalChimia renews the Crédit d’Impôt Recherche (CIR) accreditation

GalChimia has renewed the Crédit d’Impôt Recherche (CIR) accreditation from the French Government, which certifies the company as a provider of R&D services in France. The evaluation is related to the company’s participation in the SHIKIFACTORY100 European project, aimed at the production of compounds of high added value in the chemical, food and cosmetic industries. The Galician company has doubled the surface and staff of its R&D&I center at the Barcelona Science Park, which was opened two years ago to accelerate its growth and internationalization strategy. 

 

Read More

IESE opens a new call for Proposals for the Barcelona Technology Transfer Group

IESE Business School opens their 7th Edition of the program of the Barcelona Technology Transfer Group (BTTG), a collaboration program between MBA students and successful mentors with scientists, technologist and entrepreneurs of public and private centres, with the intention of helping create a company or boost their first stages of development. Barcelona Science Park collaborates in this initiative within the strategic agreement set on last January with IESE to promote and support the growth of business initiatives of life sciences.

Read More

Droplite opens seed round of 600.000€ to accelerate the manufacturing development of its smart medical diagnostics device

Droplite, located in the Parc Cientific de Barcelona (PCB), has recently started the industrial design and manufacturing development of its smart diagnostics device, focused on point of care (POC). The company, that it was born in 2018, as a spinoff of the Institute of Photonics Sciences (ICFO), from the hand of two entrepreneurs: André Guedes (CEO) and Rafael Porcar (CTO), was recognized with the Seal of Excellence by the European Union and with the Innovative SME seal from the Ministry of Science and Innovation.

 

Read More

Genesis Biomed to invest an additional €500,000 in 2020

The Genesis Ventures fund, investment vehicle of several family offices managed by the consulting firm Genesis Biomed, based in the Barcelona Science Park, has announced that it will invest an additional €500,000 in the remainder of this year. The new investments will be made in several of the spin-offs of its portfolio of companies dedicated to biomedical research, in a moment of paralysis due to health and social crisis caused by the SARS-CoV-2 coronavirus.

 

Read More

EQA develops The Conformity Assessment of Good Practice for Risk Management of COVID-19

EQA, an assessment and certification leading company accredited by ENAC (the Spain national accreditation agency) has developed The Conformity Assessment of Good Practice for Risk Management of COVID-19, as a basis for the progressive return to normality, essential for social and economic recovery. This evaluation is available for all types of facilities and services, whether they continue with their activity or prepare to start it.

 

Read More

Researchers identify a molecular auto-control system to avoid an excessive brown adipose tissue activity

A scientific team found, lead by Professor Francesc Villarroya, from the Faculty of Biology and the Institute of Biomedicine of the University of Barcelona (IBUB) present in PCB, found a new molecular auto-control system of lipidic metabolism, so far unknown, could help prevent the damaging effects derived from an excessive activation of the brown adipose tissue. The study is published in the journal Nature Communications.

 

Read More